XBIT XBiotech Inc

Price (delayed)

$2.33

Market cap

$71.04M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

-$44.42M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 8

XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally ...

Highlights
XBIT's quick ratio has soared by 143% since the previous quarter and by 34% year-on-year
XBiotech's net income has increased by 12% from the previous quarter
XBiotech's EPS has increased by 11% QoQ but it has decreased by 2.3% YoY
The equity has declined by 23% year-on-year and by 3.8% since the previous quarter

Key stats

What are the main financial stats of XBIT

XBIT stock price

How has the XBiotech stock price performed over time
Intraday
1.75%
1 week
-3.32%
1 month
-0.43%
1 year
-17.67%
YTD
-2.51%
QTD
1.3%

Financial performance

How have XBiotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$48.41M
Net income
-$40.16M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 13% QoQ but it fell by 7% YoY
XBiotech's net income has increased by 12% from the previous quarter

Price vs fundamentals

How does XBIT's price correlate with its fundamentals

Growth

What is XBiotech's growth rate over time

Valuation

What is XBiotech stock price valuation
P/E
N/A
P/B
0.53
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
XBiotech's EPS has increased by 11% QoQ but it has decreased by 2.3% YoY
The P/B is 24% lower than the 5-year quarterly average of 0.7 but 6% higher than the last 4 quarters average of 0.5
The equity has declined by 23% year-on-year and by 3.8% since the previous quarter

Efficiency

How efficient is XBiotech business performance
XBIT's ROA is down by 28% YoY but it is up by 6% QoQ
The return on equity has declined by 24% year-on-year but it rose by 6% since the previous quarter
XBIT's ROIC is up by 13% QoQ but it is down by 4.8% YoY

Dividends

What is XBIT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did XBiotech financials performed over time
The current ratio has soared by 144% from the previous quarter and by 34% YoY
XBIT's quick ratio has soared by 143% since the previous quarter and by 34% year-on-year
The debt is 100% lower than the equity
The equity has declined by 23% year-on-year and by 3.8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.